Stoneridge Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,670	Closed	-$332K	–	292
2017 Q1	$332K	Buy	+7,670	New	+$332K	0.04%	244